Halmos Highlights Effort Exploring COVID-19 Vaccines in Patients With Cancer

Season 5 Episode 18  ·  Jun 24, 2021, 06:51 PM

Headliner
Share
Subscribe

Dr. Halmos discusses the data from a study examining seroconversion rates following COVID-19 vaccination among patients with cancer and underscores the need for novel vaccination or passive immunization strategies for immunosuppressed cohorts.

Share
Subscribe
Next
Lee-Kim on Fostering a Fulfilling Fellowship in Oncology
Top episodes
DeNunzio Describes the Advantages of Proton Beam Therapy in Oncology
by OncLive® On Air
FDA Approval Insights: Amivantamab and Mobocertinib in EGFR Exon 20 Insertion+ NSCLC
by OncLive® On Air
Milhem Talks Mechanism of Action, Delivery Methodology, and Ongoing Trials With RP1
by OncLive® On Air